THC Biomed Intl Ltd.

THC

CA87243W1032

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 11:25:44 31/01/2024 pm IST			5-day change	1st Jan Change
0.02 ^CAD	-.--%		-.--%	-.--%

2023	THC Biomed Intl Ltd. Introduces Always Hi New Brand Catering to Maturing Cannabis Consumer Trends	CI
2023	Thc Biomed Intl Ltd. Launches New Summer Cannabis Product: Thc Kiss Strawberry Tangerine Gummies	CI

THC Biomed Intl Ltd. Appoints Ashish Dave to the Board

June 23, 2017 at 02:30 pm IST

THC Biomed Intl Ltd. announced that Dr. Ashish Dave has consented to join the Board. He was appointed as a Director on June 21, 2017. Dr. Dave is a scientist who has previously consulted for THC.

Latest news about THC Biomed Intl Ltd.

THC Biomed Intl Ltd. Introduces Always Hi New Brand Catering to Maturing Cannabis Consumer Trends	09/12	CI
Thc Biomed Intl Ltd. Launches New Summer Cannabis Product: Thc Kiss Strawberry Tangerine Gummies	04/23/04	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	30/23/30	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	04/23/04	CI
THC Biomed Intl Ltd. acquired 40% stake in THC BioMed Co. Ltd for $0.06 million.	03/23/03	CI
THC Biomed Intl Ltd. to Open First Medical Cannabis Dispensary in Asia	25/23/25	CI
THC Biomed Intl Ltd. Announces CBD KISS Mango Beverage Shot and CBD Biscuits Begin sales in Ontario	25/23/25	CI
THC Biomed Intl Ltd. Reports Earnings Results for the First Quarter Ended October 31, 2022	30/22/30	CI
THC Biomed Intl Ltd. Auditor Raises 'Going Concern' Doubt	24/22/24	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Full Year Ended July 31, 2022	24/22/24	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	30/22/30	CI
THC Biomed Intl Ltd. Announces Broker and Commercial Sales Agreement with World Wide Brands Limited	13/22/13	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	02/22/02	CI
THC BioMed Intl Ltd. Announces Availability of THC KISS Cannabis Biscuits to Consumers Through Ontario Cannabis Store Online and Wholesale to Ontario Retail Stores	02/22/02	CI
THC Biomed Intl Ltd. Grants Licence by Overseas Government to Cultivate Cannabis for Medical and Scientific Use	27/22/27	CI
THC Biomed Intl Ltd. announced that it has received CAD 0.25 million in funding	07/22/07	CI
THC Biomed Intl Ltd. Reports Earnings Results for the First Quarter Ended October 31, 2021	30/21/30	CI
THC Biomed Intl Ltd. Auditor Raises 'Going Concern' Doubt	29/21/29	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Full Year Ended July 31, 2021	29/21/29	CI
THC BioMed Intl Ltd. Announces Three New Products to be List and Sold through Ontario Cannabis Stores	24/21/24	CI
THC Biomed Intl Ltd. Receives Purchase Orders from 30 Dispensaries in the Province of Manitoba	23/21/23	CI
THC KISS Mango Beverage Shot Ships to BC Cannabis Stores	01/21/01	CI
THC BioMed Announces Shipment of THC KISS Cannabis Biscuits to BC Cannabis Stores	31/21/31	CI
THC BioMed Announces 2nd Shipment of THC KISS Cannabis Biscuits to Saskatchewan	26/21/26	CI
THC BioMed Announces Shipment of Kiss Mango Beverage Shot to Ontario Cannabis Stores	17/21/17	CI

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
THC BIOMED INTL LTD.	-.--%	2.4M
DONG-E-E-JIAO CO.,LTD.	+26.93%	5.55B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-33.55%	3.52B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-3.74%	3.03B
TASLY PHARMACEUTICAL GROUP CO., LTD	-26.09%	2.59B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-10.93%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.88B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+41.84%	1.46B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+47.62%	1.42B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-28.07%	1.26B

Alternative Medicine